• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Azithromycin is not associated with increased cardiovascular death in low-risk groups

bys25qthea
May 3, 2013
in Cardiology, Infectious Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Use of azithromycin did not increase risk of cardiovascular death (CVD) in a general population of young and middle-aged adults. 

Evidence Rating Level: 2 (Good) 

Study Rundown: The study finds that azithromycin is not associated with higher risk of cardiovascular death (CVD) in a general young and middle-aged population. In contrast, the Ray, et al study (see Relevant Reading) showed near 3-fold increase in CVD with azithromycin use in high risk patients. The message is one of risk stratification – azithromycin is safe for the general population with a low baseline risk of cardiovascular disease, while one must weigh benefits against potential risks in high-risk patients prone to cardiac dysrhythmias.

Click to read the study in NEJM

Relevant Reading: Azithromycin and the risk of cardiovascular death

RELATED REPORTS

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

Twice-yearly azithromycin distribution reduces childhood mortality in rural Niger

Azithromycin during routine well-infant visits does not reduce mortality

In-Depth [historical cohort study]: This study assessed the risk of death from cardiovascular causes associated with azithromycin use in a general population of young and middle-aged adults. The study compared rate of cardiovascular death (CVD) between the azithromycin group and no-use-of-antibiotics group, as well as between azithromycin and penicillin V groups.

The risk of CVD was significantly higher with current use (1 to 5 days, starting from the index date) of azithromycin compared to no use of antibiotics (rate ratio, RR, 2.85), this RR increases to 3.27 in sensitivity analysis (SA). Noncardiovascular death rate was also higher with current use of azithromycin (RR=1.60). In contrast, current use of azithromycin did not show a higher rate of CVD than penicillin V (RR=0.93 after adjusting for propensity scores; 95% CI, 0.56 to 1.55). This adjusted RR increased to 1.06 in SA.

The study concludes that azithromycin use is not associated with increased risk of CVD in a general young and middle-aged population.

By Xiaozhou Liu and Andrew Bishara

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: azithromycin
Previous Post

Patient satisfaction a poor surgical quality indicator

Next Post

School programs successfully cut number of smokers

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Infectious Disease

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

May 28, 2025
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Infectious Disease

Twice-yearly azithromycin distribution reduces childhood mortality in rural Niger

September 30, 2024
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Infectious Disease

Azithromycin during routine well-infant visits does not reduce mortality

February 8, 2024
#VisualAbstract: Azithromycin during routine well-infant visits does not prevent death in Burkina Faso
StudyGraphics

#VisualAbstract: Azithromycin during routine well-infant visits does not prevent death in Burkina Faso

January 23, 2024
Next Post
School programs successfully cut number of smokers

School programs successfully cut number of smokers

Gestational weight loss may improve outcomes for obese women

Gestational weight loss may improve outcomes for obese women

Selective estrogen receptor modulators reduce breast cancer risk even after treatment

Selective estrogen receptor modulators reduce breast cancer risk even after treatment

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression
  • Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals
  • Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.